<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
span.EmailStyle17
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-CA link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Hi all:<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>If you have taken XTANDI /Enzalutamide, you may wish to take the survey shown below.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Thx.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Glen<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'><o:p> </o:p></span></p><div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0cm 0cm 0cm'><p class=MsoNormal><b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>From:</span></b><span lang=EN-US style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> CCSN Communications [mailto:communications@survivornet.ca] <br><b>Sent:</b> September 27, 2018 11:59 AM<br><b>To:</b> glen.tolhurst@sympatico.ca<br><b>Subject:</b> Re: Canadian Cancer Survivor Network Prostate Patient Questionnaire - Enzalutamide (Xtandi)<o:p></o:p></span></p></div><p class=MsoNormal><o:p> </o:p></p><div><div><p class=MsoNormal>Hello Glen,<o:p></o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal>This is just a reminder to let you know that our prostate cancer patient questionnaire for Enzalutamide (Xtandi) ends this <b>Monday, October 1st</b>! <o:p></o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal><b><a href="https://www.surveymonkey.com/r/72VYGWC">To complete the survey, click here.</a></b><o:p></o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal>Thanks for your assistance with the distribution of this survey! Have a great weekend.<o:p></o:p></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal>Best,<o:p></o:p></p></div><div><p class=MsoNormal>Allison<o:p></o:p></p></div></div><p class=MsoNormal><o:p> </o:p></p><div><div><p class=MsoNormal>On Wed, Sep 12, 2018 at 3:01 PM CCSN Communications <<a href="mailto:communications@survivornet.ca">communications@survivornet.ca</a>> wrote:<o:p></o:p></p></div><blockquote style='border:none;border-left:solid #CCCCCC 1.0pt;padding:0cm 0cm 0cm 6.0pt;margin-left:4.8pt;margin-right:0cm'><div><p class=MsoNormal style='margin-bottom:12.0pt'>Hello Glen, I hope you're doing well!<br><br>My name is Allison MacAlister, and I'm the Communications Coordinator for the Canadian Cancer Survivor Network. I'm writing you today to let you know about a survey we're conducting in order to complete an informed patient evidence submission for a new medication for prostate cancer. <br><br>The survey is intended for patients with either metastatic or non-metastatic castration-resistant prostate cancer (CRPC) and their caregivers. <br><br>The survey information and link are below. We would greatly appreciate it if you would share the link to this survey with your networks, as we are gathering as many responses as possible across Canada. If you have any questions, please don't hesitate to contact me.<br><br>Thank you for your time!<br><br>Cheers,<br>- Allison<br><br>-------------------------------------------------<o:p></o:p></p><div><p class=MsoNormal><img border=0 width=542 height=271 id="_x0000_i1025" src="cid:image001.png@01D45719.AF3E94A0" alt="ARE YOU A CANADIAN PROSTATE CANCER PATIENT OR CAREGIVER_ (1).png"><o:p></o:p></p></div><p class=MsoNormal style='margin-bottom:12.0pt'>The purpose of the survey is to provide the <b>Canadian Cancer Survivor Network (CCSN)</b> with insights and perspectives about living with and managing <b>castrate resistant prostate cancer (CRPC)</b> from patients and caregivers in order to complete a patient evidence submission for a new medication for non-metastatic castration-resistant prostate cancer called <b>Enzalutamide (Xtandi). <br></b><br><b>We are looking for input from patients with both metastatic or non-metastatic castration-resistant prostate cancer (mCRPC) and their caregivers. </b>The purpose of this survey is to understand the experience with Enzalutamide (Xtandi) or the need for Enzalutamide to prolong progression from non-metastatic to metastastic disease. If you are a patient outside of this specification and feel you may also benefit from this treatment, we would like to hear from you as well.<br><br>The pan-Canadian Oncology Drug Review invites patient groups like CCSN to prepare and send in submissions so that patients and caregivers like you can be heard. Please join us and have your voice included in this important submission process.<br><br>The survey only takes about ten minutes to complete, and will remain open until <b>October 3rd, 2018.<br><br></b><o:p></o:p></p><p class=MsoNormal align=center style='text-align:center'><b><span style='font-size:13.5pt'><a href="https://www.surveymonkey.com/r/72VYGWC" target="_blank">Click here to take the survey!</a></span></b><o:p></o:p></p><div><p class=MsoNormal><o:p> </o:p></p></div><p class=MsoNormal>-- <o:p></o:p></p><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><p class=MsoNormal><b><span style='font-size:9.5pt'>Allison MacAlister</span></b><span style='font-size:9.5pt'><o:p></o:p></span></p></div><div><p class=MsoNormal><b><span style='font-size:9.5pt'>Communications and Social Media Coordinator</span></b><span style='font-size:9.5pt'><o:p></o:p></span></p></div><div><p class=MsoNormal><b><span style='font-size:9.5pt'>Coordonnatrice, Communications et médias sociaux</span></b><span style='font-size:9.5pt'><o:p></o:p></span></p></div><div><p class=MsoNormal><span style='font-size:9.5pt'>Canadian Cancer Survivor Network<o:p></o:p></span></p></div><div><p class=MsoNormal><span style='font-size:9.5pt'>Réseau canadien des survivants du cancer<o:p></o:p></span></p></div><div><p class=MsoNormal><span style='font-size:9.5pt'>1750 croissant Courtwood Crescent, Suite 210<o:p></o:p></span></p></div><div><p class=MsoNormal><span style='font-size:9.5pt'>Ottawa, ON K2C 2B5<o:p></o:p></span></p></div><div><p class=MsoNormal><span style='font-size:9.5pt'>Telephone / Téléphone : <a href="tel:613-898-1871" target="_blank"><span style='color:#1155CC'>613-898-1871</span></a><o:p></o:p></span></p></div><div><p class=MsoNormal><span style='font-size:9.5pt'>E-mail / Courriel : <a href="mailto:communications@survivornet.ca" target="_blank">communications<span style='color:#1155CC'>@survivornet.ca</span></a><o:p></o:p></span></p></div><div><p class=MsoNormal><span style='font-size:9.5pt'>Web site / site web: <a href="http://www.survivornet.ca/" target="_blank"><span style='color:#1155CC'>www.survivornet.ca</span></a><o:p></o:p></span></p></div><div><p class=MsoNormal><span style='font-size:9.5pt'>Twitter: @<a href="http://www.twitter.com/survivornetca" target="_blank"><span style='color:#1155CC'>survivornet</span>ca</a><br>------------------------------------------------------------<o:p></o:p></span></p></div><p class=MsoNormal><img border=0 width=200 height=65 id="_x0000_i1026" src="https://docs.google.com/uc?export=download&id=1_TTnbuXZhZCWbEl8_rhbND37fzJFvODV&revid=0B5ATa4dYsL_LTVlWcktEdm5PRWw5NDl6UklZbEhxeHVRK1hZPQ"><o:p></o:p></p></div><p class=MsoNormal><b><a href="https://register.gotowebinar.com/register/9030239914313835267" target="_blank">Register now for our next free webinar! Liver Cancer 101: Causes, Treatments, Innovations & Access</a></b><o:p></o:p></p></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></blockquote></div><p class=MsoNormal><br clear=all><o:p></o:p></p><div><p class=MsoNormal><o:p> </o:p></p></div><p class=MsoNormal>-- <o:p></o:p></p><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><div><p class=MsoNormal><b><span style='font-size:9.5pt'>Allison MacAlister</span></b><span style='font-size:9.5pt'><o:p></o:p></span></p></div><div><p class=MsoNormal><b><span style='font-size:9.5pt'>Communications and Social Media Coordinator</span></b><span style='font-size:9.5pt'><o:p></o:p></span></p></div><div><p class=MsoNormal><b><span style='font-size:9.5pt'>Coordonnatrice, Communications et médias sociaux</span></b><span style='font-size:9.5pt'><o:p></o:p></span></p></div><div><p class=MsoNormal><span style='font-size:9.5pt'>Canadian Cancer Survivor Network<o:p></o:p></span></p></div><div><p class=MsoNormal><span style='font-size:9.5pt'>Réseau canadien des survivants du cancer<o:p></o:p></span></p></div><div><p class=MsoNormal><span style='font-size:9.5pt'>1750 croissant Courtwood Crescent, Suite 210<o:p></o:p></span></p></div><div><p class=MsoNormal><span style='font-size:9.5pt'>Ottawa, ON K2C 2B5<o:p></o:p></span></p></div><div><p class=MsoNormal><span style='font-size:9.5pt'>Telephone / Téléphone : <a href="tel:613-898-1871" target="_blank"><span style='color:#1155CC'>613-898-1871</span></a><o:p></o:p></span></p></div><div><p class=MsoNormal><span style='font-size:9.5pt'>E-mail / Courriel : <a href="mailto:communications@survivornet.ca" target="_blank">communications<span style='color:#1155CC'>@survivornet.ca</span></a><o:p></o:p></span></p></div><div><p class=MsoNormal><span style='font-size:9.5pt'>Web site / site web: <a href="http://www.survivornet.ca/" target="_blank"><span style='color:#1155CC'>www.survivornet.ca</span></a><o:p></o:p></span></p></div><div><p class=MsoNormal><span style='font-size:9.5pt'>Twitter: @<a href="http://www.twitter.com/survivornetca" target="_blank"><span style='color:#1155CC'>survivornet</span>ca</a><br>------------------------------------------------------------<o:p></o:p></span></p></div><p class=MsoNormal><a href="https://register.gotowebinar.com/register/9030239914313835267" target="_blank"><span style='text-decoration:none'><img border=0 width=200 height=65 id="_x0000_i1027" src="https://docs.google.com/uc?export=download&id=1_TTnbuXZhZCWbEl8_rhbND37fzJFvODV&revid=0B5ATa4dYsL_LTVlWcktEdm5PRWw5NDl6UklZbEhxeHVRK1hZPQ"><img border=0 width=200 height=66 id="_x0000_i1028" src="https://docs.google.com/uc?export=download&id=1XWm3LBl0lFrXYb6dSqw8XwpjJcJmgylG&revid=0B5ATa4dYsL_LOTc5ZytKRVRnNk5hRk1jTlE1NFFGZFE3YmI4PQ"></span></a><o:p></o:p></p></div><p class=MsoNormal><a href="https://register.gotowebinar.com/register/9030239914313835267" target="_blank"><b>Register now for our next free webinar! </b><b><span style='color:#0000EE'>Liver Cancer 101: Causes, Treatments, Innovations & Access</span></b></a><o:p></o:p></p></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></body></html>